Literature DB >> 24517559

Statin-associated necrotizing autoimmune myopathy.

Geórgea Hermogenes Fernandes1, Edmar Zanoteli, Samuel Katsuyuki Shinjo.   

Abstract

Necrotizing autoimmune myopathy (NAM) is a severe adverse effect of statins. We report a 66-year-old Caucasian female who had progressive proximal muscle weakness after treatment with statins. Results of a muscle biopsy showed necrotizing myopathy with minimal inflammatory cell infiltrate and increased major histocompatibility class I antigen expression in muscle fibers. The clinical and laboratory parameters improved significantly with immunosuppressive treatment. Although it is a rare event, statin-induced NAM should be included as a differential diagnosis of myopathies.

Entities:  

Keywords:  Dyslipidemia; Myopathy; Myositis; Necrotizing autoimmune myopathy; Statin

Mesh:

Substances:

Year:  2014        PMID: 24517559     DOI: 10.3109/14397595.2013.874739

Source DB:  PubMed          Journal:  Mod Rheumatol        ISSN: 1439-7595            Impact factor:   3.023


  2 in total

Review 1.  Toward Omics-Based, Systems Biomedicine, and Path and Drug Discovery Methodologies for Depression-Inflammation Research.

Authors:  Michael Maes; Gabriel Nowak; Javier R Caso; Juan Carlos Leza; Cai Song; Marta Kubera; Hans Klein; Piotr Galecki; Cristiano Noto; Enrico Glaab; Rudi Balling; Michael Berk
Journal:  Mol Neurobiol       Date:  2015-05-02       Impact factor: 5.590

2.  Autoimmune statin-induced myopathy: a case report.

Authors:  Jonathan B Young; Ibrahim I Ghobrial
Journal:  J Community Hosp Intern Med Perspect       Date:  2015-09-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.